Previous Page  10 / 15 Next Page
Information
Show Menu
Previous Page 10 / 15 Next Page
Page Background

Page 52

conferenceseries

.com

Volume 6, Issue 6 (Suppl)

OMICS J Radiol, an open access journal

ISSN: 2167-7964

Neuroradiology 2017

October 30 to November 01, 2017

October 30 to November 01, 2017 | San Antonio, USA

2

nd

International Conference on

Neuroscience, Neuroimaging & Interventional Radiology

Advances in the imaging of Alzheimer’s disease

Nadia M Biassou

1

National Institutes of Health, USA

2

George Washington University School of Medicine, USA

A

lzheimer’s disease is a fatal neurodegenerative disease with growing incidence in the world. The US CDC estimates that nearly

15 million Americans will be diagnosed with the disease by the year 2050. Similar statistics are cited for EU, China and Latin

America. It has become a worldwide priority for primary care physicians to accurately evaluate the clinical presentations of their

patients and to identify early neuroimaging biomarkers associated with the disease for increased diagnostic certainty and improved

clinical management. Identifying the earliest neuroimaging biomarkers is becoming an essential and increasingly important role for

the neuroradiologist.

biassoun@cc.nih.gov nadia@jantio.com

OMICS J Radiol 2017, 6:6, (Suppl)

DOI: 10.4172/2167-7964-C1-019